Price
$44.09
Decreased by -6.59%
Dollar Volume
11.93 M
ADR%
4.29
Earnings Report Date (estimate)
Feb 21, 23 (-0.18)
Market Cap.
2.05 B
Shares Float
45.21 M
Shares Outstanding
46.51 M
Beta
1.30
Price / Earnings
37.68
BPR
58.70
20D Range
40.49 47.85
50D Range
40.49 47.85
200D Range
32.51 62.19
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Nov 1, 22 -0.27
Decreased by -112.80%
-0.25
Decreased by -8.00%
Aug 2, 22 -0.32
Increased by +11.11%
-0.29
Decreased by -10.34%
May 3, 22 -0.33
Increased by +13.16%
-0.32
Decreased by -3.13%
Feb 15, 22 -0.30
Decreased by -7.14%
-0.29
Decreased by -3.45%
Nov 3, 21 2.11
Increased by +2.02 K%
-0.32
Increased by +759.37%
Aug 4, 21 -0.36
Decreased by -80.00%
-0.33
Decreased by -9.09%
Apr 27, 21 -0.38
Increased by +9.52%
-0.37
Decreased by -2.70%
Feb 23, 21 -0.28
Increased by +33.33%
-0.28
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 83.25 M
Increased by +18.15%
-12.27 M
Decreased by -112.64%
Decreased by -14.74%
Decreased by -110.70%
Jun 30, 22 84.53 M
Increased by +18.43%
-14.84 M
Increased by +8.68%
Decreased by -17.56%
Increased by +22.89%
Mar 31, 22 74.58 M
Increased by +25.81%
-15.18 M
Increased by +10.25%
Decreased by -20.36%
Increased by +28.66%
Dec 31, 21 73.22 M
Increased by +26.84%
-13.74 M
Increased by +25.97%
Decreased by -18.77%
Increased by +41.64%
Sep 30, 21 70.46 M
Increased by +28.68%
97.11 M
Increased by +2.06 K%
Increased by +137.82%
Increased by +1.62 K%
Jun 30, 21 71.38 M
Increased by +74.84%
-16.25 M
Decreased by -97.32%
Decreased by -22.77%
Decreased by -12.86%
Mar 31, 21 59.27 M
Increased by +11.37%
-16.92 M
Decreased by -3.10%
Decreased by -28.54%
Increased by +7.42%
Dec 31, 20 57.73 M
Decreased by -5.86%
-18.56 M
Decreased by -15.32%
Decreased by -32.16%
Decreased by -22.50%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.